1887

oa SA Pharmaceutical Journal - New product focus : drug info

 

Abstract

Telmisartan is approved for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents, including a fixed-dose combination with hydrochlorothiazide.

Loading

Article metrics loading...

/content/mp_sapj/77/7/EJC82433
2010-08-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error